The microcatheter that started it all, offering trusted precision and effectiveness.
Engineered and precision-crafted in our state-of-the-art facilities
Pressurized viscodilation with catheterization across the entire 360° of the conventional outflow pathway.
What I like best about the iTrack™ system is that it doesn’t destroy future options for glaucoma treatment. I can do any other glaucoma treatment that I want to after iTrack™. With other treatments, that's not true. Once you scar down a lot of conjunctiva you've reduced your options. Or, you open up the canal a lot and you'll scar closed. You can't put a device in that space.
Robert Noecker, MD (USA)
The problem for me is that we don't know where the resistance to outflow is preoperatively. Is it the trabecular meshwork? Is it the Schlemm's canal? Are the distal channels working well or not? With iTrack™, there's no need to target a specific procedure or specific device into one part of the canal because we're opening up the entire system. It’s kind of like hedging our bets.
Inder P. Singh, MD (USA)
I view the angle as the new conjunctiva, because I want to manipulate it today – but I also want to preserve tissue. We all know that, in glaucoma, there's not a single procedure that lasts forever. I want to be able to come back and treat the patient with SLT over 360 degrees. I want to be able to implant micro stents in the future, or even try to rejuvenate the system again with another iTrack™ procedure.
Mark J. Gallardo, MD (USA)
Over two decades of excellence with iTrack™
